Crescent Grove Advisors’s RiverNorth Market Neutral ETF RNMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$726K Sell
27,855
-1,276
-4% -$33K 0.06% 154
2026
Q1
$743K Hold
29,131
0.07% 154
2025
Q4
$744K Hold
29,131
0.07% 152
2025
Q3
$829K Hold
29,131
0.08% 133
2025
Q2
$788K Sell
29,131
-1,135
-4% -$30.8K 0.08% 130
2025
Q1
$799K Hold
30,266
0.08% 120
2024
Q4
$786K Sell
30,266
-3,844
-11% -$103K 0.08% 125
2024
Q3
$916K Sell
34,110
-8,565
-20% -$227K 0.09% 121
2024
Q2
$1.13M Sell
42,675
-570
-1% -$15K 0.12% 105
2024
Q1
$1.13M Sell
43,245
-17,615
-29% -$457K 0.12% 112
2023
Q4
$1.57M Buy
60,860
+2,750
+5% +$73.9K 0.17% 83
2023
Q3
$1.56M Sell
58,110
-13,400
-19% -$358K 0.19% 78
2023
Q2
$1.89M Buy
71,510
+9,730
+16% +$255K 0.2% 70
2023
Q1
$1.61M Buy
+61,780
New +$1.59M 0.19% 75

Other funds holding RNMN

Crescent Grove Advisors's RNMN Position: Q2 2026 in Review

Crescent Grove Advisors reduced its RiverNorth Market Neutral ETF (RNMN) stake by 4.4% in Q2 2026, selling an estimated $33K and leaving 27,855 shares worth $726K. The position accounts for 0.06% of the portfolio, ranked #154.

Crescent Grove Advisors first reported a position in RNMN in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.89M in Q2 2023. 3 funds tracked by Wall St. Rank hold RNMN as of Q2 2026.

  • Crescent Grove Advisors held 27,855 shares of RiverNorth Market Neutral ETF worth $726K as of Q2 2026.
  • Crescent Grove Advisors sold 1,276 RiverNorth Market Neutral ETF shares in Q2 2026, an estimated $33K.
  • RiverNorth Market Neutral ETF made up 0.06% of Crescent Grove Advisors's portfolio in Q2 2026, its #154 holding.
  • Crescent Grove Advisors first reported a position in RiverNorth Market Neutral ETF in Q1 2023 and has held it in 14 quarters since.
  • Crescent Grove Advisors's RiverNorth Market Neutral ETF position peaked at $1.89M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held RiverNorth Market Neutral ETF as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.